Related Experiment Videos
[Cytogenetic abnormalities in acute lymphoblastic leukemia].
M Martín Ramos1, F Fernández Martínez, E Barreiro Miranda
1Servicio de Genética, Hospital 12 de Octubre, Madrid, Spain. mlmartin@tdi.es
Anales Espanoles De Pediatria
|June 20, 2001
Summary
Cytogenetic analysis reveals specific chromosomal abnormalities in childhood acute lymphoblastic leukemia (ALL) that predict patient outcomes. These findings guide risk-stratified therapy, improving treatment strategies for pediatric ALL.
Area of Science:
- Pediatric Oncology
- Human Genetics
- Molecular Biology
Context:
- Childhood acute lymphoblastic leukemia (ALL) is a common pediatric cancer.
- Cytogenetic analysis of leukemia blast cells is crucial for understanding disease biology.
- Non-random chromosomal abnormalities are frequently observed in ALL patients.
Purpose:
- To review the most significant chromosomal abnormalities in childhood ALL.
- To discuss the prognostic and therapeutic implications of these genetic alterations.
- To highlight the role of cytogenetics in risk stratification for pediatric ALL.
Summary:
- Cytogenetic analysis identifies specific chromosomal abnormalities in childhood ALL, including numerical (ploidy) and structural changes (translocations, inversions, deletions).
- These abnormalities are linked to distinct cytomorphological and immunological subtypes of ALL.
- Karyotype results serve as independent prognostic indicators, distinguishing between favorable and poor outcomes.
Impact:
- Cytogenetic findings significantly impact patient management by enabling risk-adapted therapeutic strategies.
- Hyperdiploidy (≥51 chromosomes) is associated with a favorable prognosis.
- Specific translocations, such as the Philadelphia chromosome t(9;22) and t(4;11), indicate a poor prognosis, necessitating intensified treatment.